The evidence of reciprocal regulation of c-Myc and AR expression, co-expression in castration-resistant prostate cancer, and ligand-independent AR activation by c-Myc [36–38] may explain the genomic instability or metabolic changes observed in prostate cancer. The gene discussed is MYC; the disease is prostate carcinoma.